Bailard’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$12.4K Sell
2023
Q2
$67.3K Buy
2023
Q1
$31.6K Buy
2021
Q4
Sell
2021
Q3
$401K Sell
2021
Q2
$1.64M Buy
2021
Q1
$342K Buy